Pearls from the CMV guidelines
Camille N. Kotton (US)
Clinical Director, Transplant infectious disease · Infectious DIseases · Massachusetts General Hospital · Boston
Camille Nelson Kotton, MD, FIDSA, FAST, is the clinical director of the Transplant and Immunocompromised Host Infectious Diseases Program in the Infectious Diseases Division at Massachusetts General Hospital, and associate professor of medicine at Harvard Medical School in Boston, MA.
Dr Kotton’s clinical interests include cytomegalovirus, vaccines, donor-derived infections, zoonoses, and travel and tropical medicine in the transplant setting. She was a member of the CDC Advisory Committee on Immunization Practices (ACIP) 2020-2024 and was involved in national decisions regarding COVID-19 and other vaccines.
Dr Kotton has served as the chair of The Infectious Disease Community of Practice of The American Society of Transplantation. She has also served as the president of The Transplant Infectious Disease Section of The Transplantation Society. Highlights of her work include the development of 4 versions of the international guidelines on CMV management after solid organ transplant and updated international guidelines on BK management, all published in Transplantation. She is the first transplant infectious disease specialist to be on the executive committee of The Transplantation Society.